Insider Cluster (2 insiders) ·Filed Jun 16, 2026

TVTX

Travere Therapeutics, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed3mo ago
Insider cluster: 2 insiders, $726K total
Actionable Insight • Neutral

This insider cluster is routine and non-informative. No trading action is warranted based on these small director sales. Monitor for any upcoming corporate events (e.g., earnings, pipeline updates) that could provide a catalyst, but this filing alone does not change the outlook.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d ⚠ clustered
TVTX ▲ +22.22% at T+60d
NEUTRAL call ✓ call won +22.22% · α vs SPY +19.07% · entry $54.14 → $66.17
Entry anchored
Jun 16, 03:59 PM ET
via exchange tick
T+1d
+1.87%
call +1.87% · α +1.09%
$55.15
settled 4mo ago
T+5d
+6.56%
call +6.56% · α +7.60%
$57.69
settled 3mo ago
T+20d
+2.11%
call +2.11% · α +0.79%
$55.28
settled 3mo ago
T+60d
+22.22%
call +22.22% · α +19.07%
$66.17
settled 21d ago

Price Chart

Loading chart...

Executive Summary

Two directors of Travere Therapeutics (TVTX) exercised stock options and immediately sold the resulting shares on June 12, 2026, for a total of ~$726K in open-market sales. The combined sales represent only 0.015% of the company's $5.0B market cap, making this a routine, liquidity-driven transaction with no material informational content.

Key Financial Metrics

Direction
selling
Total Value
$725.7K
Insiders
2

Key Facts

  • Directors Timothy Coughlin and Roy D. Baynes each exercised stock options and sold shares on June 12, 2026.
  • Coughlin sold 10,000 shares at $50.07 for $500,747; Baynes sold 4,500 shares at $50.00 for $225,000.
  • Total open-market sales: $725,747, or ~0.015% of TVTX's $5.0B market cap.
  • Both sales followed option exercises (cash and non-cash), indicating a typical exercise-and-sell pattern rather than a bearish signal.
  • No C-suite executives participated in the cluster; only directors transacted.

Financial Impact

Trivial — $726K in sales is immaterial relative to $5.0B market cap.

dilutioninsider ownership

Risk Factors

  • No material risks identified from this filing.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
90% bullish (21 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-TVTX-1781642857007
16 reports for TVTX
Performance horizon
100% Hit rate 7 of 7 directional calls best @ T+60▲ +56.24%Jun 2, 2026
Filters
Rows
Reports for TVTX — sortable, filterable
TypeNow
Jul 9, 2026
12w ago
8-K
NEUTRAL ★ 2/10
$56.59 $61.32▲ +8.36%▲ +5.93%$56.93 (+0.60%)
Jun 16, 2026
15w ago
Insider Cluster
NEUTRAL ★ 2/10
$54.14 $55.28▲ +2.11%▲ +0.79%$56.93 (+5.15%)
Jun 16, 2026
15w ago
8-K
NEUTRAL ★ 2/10
$54.14 $55.28▲ +2.11%▲ +0.79%$56.93 (+5.15%)
Jun 12, 2026
16w ago
144
NEUTRAL ★ 2/10
$52.04 $56.59▲ +8.74%▲ +6.96%$56.93 (+9.40%)
Jun 2, 2026
17w ago
8-K
BULLISH ★ 6/10
$42.96 $56.34▲ +31.15%▲ +32.71%$56.93 (+32.52%)
May 15, 2026
20w ago
144
NEUTRAL ★ 2/10
$42.59 $53.80▲ +26.32%▲ +24.20%$56.93 (+33.67%)
May 5, 2026
21w ago
144
NEUTRAL ★ 2/10
$44.76 $45.20▲ +0.98%▼ −1.80%$56.93 (+27.19%)
May 4, 2026
21w ago
144
NEUTRAL ★ 3/10
$44.80 $42.96▼ −4.11%▼ −9.06%$56.93 (+27.08%)
May 1, 2026
22w ago
Insider Cluster
BEARISH ★ 6/10
$44.12 $45.04▼ −2.09%▲ +3.20%$56.93 (−29.03%)
Apr 15, 2026
24w ago
144
NEUTRAL ★ 3/10
$40.95 $42.84▲ +4.62%▼ −1.43%$56.93 (+39.02%)
Showing 10 of 16

US Market Status

Market Closed — Opens Mon (64h 59m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jun 16, 2026